Submitted for publication November 19, 1990 Somatostatin (33-14) is known as an antigrowth factor for a variety of cell types, including gastrointestinal mucosa, exocrine pancreas, lymphocytes, and some tumors.
We has been tried in the treatment of gut endocrine tumors with some response [7] . We have recently identified and biochemically characterized an SS-14 binding protein on rat liver plasma membranes [8, 91 . The presence of SS-14 binding protein in the liver has also been confirmed by studies demonstrating hepatic uptake of intraportally injected '251-[Tyr11]-SS-14 in a manner partially blocked by excess unlabeled . These results led us to hypothesize that SS-14 may affect liver growth as well. There have been several reports documenting the inhibitory effects of SS-14 on liver growth [ll, 121. However, little is known about the cellular mechanisms of this antiproliferative effect. In previous studies using other cell types, SS-14 has been shown to inhibit various cellular events by attenuating the production of cellular cyclic AMP (CAMP), an effect that seems to be mediated via pertussis toxinsensitive inhibitory guanine nucleotide-binding proteins [13, 141 . A number of physiological findings, using CAMP analogues such as dibutyryl-CAMP (db-CAMP), suggests that attenuation of CAMP production is not sufficient to serve as the only signal for eliciting this kind of inhibition [15, 161. technique [17, 181. Briefly, rat liver was perfused for 10 min with Mg2+/Ca2+ free Hank's buffer at 37°C followed by 8-10 min with Eagle's minimum essential medium (MEM) with 0.05% collagenase (type I). The liver was excised and placed in petri dish containing fresh MEM with collagenase. The liver capsule was stripped and cells were released by gentle manipulation,
The resulting crude preparation was filtered through 250 and 100 pm nylon mesh and collagenase was inactivated with 0.5 ml of fetal calf serum (FCS). Centrifugal separation was employed to minimize contamination by nonparenchyma1 cells. The cell viability was tested by trypan blue exclusion (>90%). The hepatocytes were plated at a cell density of lo5 per 16-mm tissue culture dish coated with 250 ~1 (1:3 v/v) of Matrigel (laminin, heparan sulfate, type IV collagen) [19] . When cultured on Matrigel, hepatocytes attached rapidly but exhibited minimal spreading ( Fig. 1) [19], which was different from the flattened appearance of hepatocytes cultured on plastic. To check the purity of the isolated hepatocytes and to exclude a possibility of toxicity by reagents, total protein secreted by hepatocytes into the media was measured after the method of Bradford, with a Bio-Rad protein assay kit. Throughout the 48hr experiment, there was no significant difference in protein secretion in presence of dibutyryl-CAMP (1 mM), IBMX (0.1 n&f), SS-14 (10 nM), and known hepatotrophic factors, such as insulin (100 rig/ml) or epidermal growth factor (EGF, 100 ng/ of the number of labeled nuclei. After a 24-hr attachment period, media were changed and the appropriate reagents were added. 13H] thymidine (-2 &i/dish) was added 6 hr after change of media. Using Dispase (a neutral protease produced by Bacillus polymyxa) [23] for 2 hr at 37"C, cells were harvested 24 hr after medium change. Half of the harvested cells were processed for counting, and the other half were used to determine DNA content. The former half was filtered onto GF/C Whatman filters and rinsed with 1 ml of icecold 15% trichloroacetic acid (TCA, ~2) and with 70% ethanol (Xl) .
Filters were dried and placed in 10 ml of scintillation cocktail (EcoLite) and were counted in a scintillation counter (Beckman LS 6000LL Freshly isolated hepatocytes (105/ml) were incubated with the appropriate reagents for 5 min. After the incubation period, the test tubes were placed in an ice-water bath for 10 min, then vortexed gently, and centrifuged at 18OOg for 10 min at 4°C. The pellet was deproteinized with 15% TCA, ether extracted, and lyophilized. Cyclic AMP levels were measured by competitive protein binding assay using an Amersham kit.
Statistical Analysis
All values shown represent the mean +-SEM. Wilcoxon signed rank test was used for comparing group means. The level of significance was established at P < 0.05.
RESULTS

Effect of Dibutyryl-CAMP on [3Hj Thymidine Incorporation
As shown in Fig. 3 , there was dose-dependent stimulation of [3H]thymidine incorporation by dibutyryl-CAMP ( 10m7 to 10e3 M). The 1 mM dose was most effective and hence used for the remaining experiments.
Effect of SS-14 on Dibuty&cAMP-Stimulated DNA Synthesis Addition of dibutyryl-CAMP (1 m&f) resulted in a 252% increase in [3H]thymidine incorporation compared to controls. SS-14 (10 nM) significantly inhibited this stimulation (Fig. 4) . Of the tested doses (0.1 to 10 nM), 10 nM of SS-14 was most effective. We thus used this dose of SS-14 in this study. Dibutyryl-CAMP also increased labeling index of hepatocytes, which was significantly inhibited by SS-14 (Table 2) The labeling index, i.e., the percentage of nuclei with 13H]thymidine, was measured as described under Materials and Methods. Data are the mean t SEM from 7-10 determinations from two different experiments. * P < 0.01 vs control. ** P < 0.01 vs db-CAMPor IBMX-stimulated labeling index.
was significantly increased by IBMX (0.1 mM) and this response was inhibited by 10 nM SS-14 (Fig. 6 ).
DISCUSSION
We have shown that dibutyryl-CAMP (a nonhydrolyzable analog of CAMP) and IBMX (an inhibitor of CAMP phosphodiesterase), both of which may increase intracellular CAMP, stimulate hepatocyte DNA synthesis. By using CAMP analogues, we could bypass signal transduction from receptor to the production of CAMP. SS-14 is known to inhibit dibutyryl-CAMP-stimulated gastric parietal cell activity (aminopyrine uptake) [29] . Koch reported that SS-14 inhibited S-Br-CAMP (another CAMP analogue)-stimulated prolactin release from pituitary cells [ 131. In our study, using rat hepatocytes, SS-14 significantly inhibited dibutyryl-CAMPstimulated
[3H]thymidine incorporation.
The data suggest that inhibitory actions of SS-14 are both proximal and distal to activation of adenylate cyclase. Similar observations have recently been reported in the growth study using the FRTL5 line of rat thyroid follicular cells [32] .
In conclusion, SS-14 may exert at least part of its antiproliferative effect via the adenylate cyclase system. However, we must investigate the possibility that the antiproliferative effect of SS-14 may be mediated via multiple pathways because SS-14 has recently been shown to inhibit DNA synthesis of thyroid follicular cells stimulated by insulin-like growth factor I, which is not dependent on CAMP [32] . Further study on other signal transduction systems may yield more information about mechanisms of hepatocyte growth. 
